Mesenchymal stem cells exploit extracellular matrix as mechanotransducer

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Li, Bojun ^a   Moshfegh, Cameron ^a   Lin, Zhe ^a   Albuschies, Jörg ^a   Vogel, Viola ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Biophysics; Biotechnology; Cell Biology; Stem Cells; Subject Areas

Indexed keywords

FIBRONECTIN; SCLEROPROTEIN;

ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; EXTRACELLULAR MATRIX; HUMAN; MECHANOTRANSDUCTION; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

CELL DIFFERENTIATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS;

EID: 84882786846     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02425     Document Type: Article

References (57)

1. Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versusregenerative medicine. J. Cell. Physiol. 213, 341-347 (2007). (Pubitemid 47509711)
2. Sanchez-Ramos, J. et al. Adult bone marrow stromal cells differentiate into neuralcells in vitro. Exp. Neurol. 164, 247-256 (2000). (Pubitemid 32008970)
3. Reyes, M. et al. Origin of endothelial progenitors in human postnatal bonemarrow. J. Clin. Invest. 109, 337-346 (2002). (Pubitemid 34141807)
4. Tomä, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J. & Kessler, P. D. Humanmesenchymal stem cells differentiate to äcardiomyocyte phenotype in the adultmurine heart. Circulation 105, 93-98 (2002). (Pubitemid 34049148)
5. Miyaharä, Y. et al. Monolayered mesenchymal stem cells repair scarredmyocardium after myocardial infarction. Nat. Med. 12, 459-465 (2006).
6. Parekkadan, B. & Milwid, J. M. Mesenchymal Stem Cells as Therapeutics. Annu.Rev. Biomed. Eng. 12, 87-117 (2010).
7. McBeath, R., Pirone, D. M.,Nelson, C. M., Bhadriraju, K. & Chen, C. S. Cell shape,cytoskeletal tension, and RhoÄregulate stem cell lineage commitment. Dev. Cell 6,483-495 (2004). (Pubitemid 38456178)
8. Engler, A. J., Sen, S., Sweeney, H. L. & Discher, D. E. Matrix elasticity directs stemcell lineage specification. Cell 126, 677-689 (2006). (Pubitemid 44233625)
9. Dalby, M. J. et al. The control of human mesenchymal cell differentiation usingnanoscale symmetry and disorder. Nat. Mater. 6, 997-1003 (2007). (Pubitemid 350210577)
10. Oh, S. et al. Stem cell fate dictated solely by altered nanotube dimension. Proc.Natl. Acad. Sci. U. S. A. 106, 2130-2135 (2009).
11. Trappmann, B. et al. Extracellular-matrix tethering regulates stem-cell fate. Nat.Mater. 11, 642-649 (2012).
12. Huebsch, N. et al. Harnessing traction-mediated manipulation of the cell/matrixinterface to control stem-cell fate. Nat. Mater. 9, 518-526 (2010).
13. Khetan, S. et al. Degradation-mediated cellular traction directs stem cell fate incovalently crosslinked three-dimensional hydrogels. Nat. Mater. 12, 458-465(2013).
14. Viswanathan, P., Chirasatitsin, S., Ngamkham, K., Engler, A. J.& Battaglia, G. Cellinstructive microporous scaffolds through interface engineering. J. Am. Chem.Soc. 134, 20103-20109 (2012).
15. Hynes, R. O. The extracellular matrix: not just pretty fibrils. Science 326,1216-1219 (2009).
16. Hynes, R. O. Fibronectins. Springer-Verlag, New York, (1990).
17. Baneyx, G., Baugh, L. & Vogel, V. Fibronectin extension and unfolding within cellmatrix fibrils controlled by cytoskeletal tension. Proc. Natl. Acad. Sci. U. S. A. 99,5139-5143 (2002). (Pubitemid 34411516)
18. Zhong, C. et al. Rho-mediated contractility exposes äcryptic site in fibronectinand induces fibronectin matrix assembly. J. Cell Biol. 141, 539-551 (1998). (Pubitemid 28237100)
19. Klotzsch, E. et al. Fibronectin forms the most extensible biological fibersdisplaying switchable force-exposed cryptic binding sites. Proc. Natl. Acad. Sci.U. S. A. 106, 18267-18272 (2009).
20. Little, W. C., Schwartlander, R., Smith, M. L., Gourdon, D. & Vogel, V. Stretchedextracellular matrix proteins turn fouling and are functionally rescued by thechaperones albumin and casein. Nano Lett. 9, 4158-4167 (2009).
21. Chabriä, M., Hertig, S., Smith, M. L. & Vogel, V. Stretching fibronectin fibresdisrupts binding of bacterial adhesins by physically destroying an epitope. Nat.Commun. 1, 135 (2010).
22. Phillips, J. E., Petrie, T. A., Creighton, F. P. & Garcíä, A. J. Human mesenchymalstem cell differentiation on self-assembled monolayers presenting differentsurface chemistries. ActäBiomater. 6, 12-20 (2010).
23. Keselowsky, B. G., Collard, D. M. & García, A. J. Integrin binding specificityregulates biomaterial surface chemistry effects on cell differentiation. Proc. Natl.Acad. Sci. U. S. A. 102, 5953-5957 (2005). (Pubitemid 40594236)
24. Keselowsky, B. G., Collard, D. M. & García, A. J. Surface chemistry modulatesfibronectin conformation and directs integrin binding and specificity to controlcell adhesion. J. Biomed. Mater. Res. Ä66, 247-259 (2003). (Pubitemid 37517224)
25. Antiä, M., Baneyx, G., Kubow, K. E. & Vogel, V. Fibronectin in aging extracellularmatrix fibrils is progressively unfolded by cells and elicits an enhanced rigidityresponse. Faraday Discuss. 139, 229-249; discussion 309-225, 419-220 (2008).
26. Vogel, V. Mechanotransduction involving multimodular proteins: convertingforce into biochemical signals. Annu. Rev. Biophys. Biomol. Struct. 35, 459-488(2006). (Pubitemid 43877387)
27. Little, W. C., Smith,M. L., Ebneter, U.& Vogel, V. Assay to mechanically tune andoptically probe fibrillar fibronectin conformations from fully relaxed to breakage.Matrix Biol. 27, 451-461 (2008).
28. Pierschbacher, M. D. & Ruoslahti, E. Variants of the cell recognition site offibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A81, 5985-5988 (1984). (Pubitemid 15219582)
29. Redick, S. D., Settles, D. L., Briscoe, G. &Erickson,H. P.Defining fibronectin's celladhesion synergy site by site-directed mutagenesis. J Cell Biol 149, 521-527(2000). (Pubitemid 30227165)
30. Takagi, J., Strokovich, K., Springer, T. A. & Walz, T. Structure of integrinalpha5beta1 in complex with fibronectin. Embo J 22, 4607-4615 (2003).
31. Sechler, J. L. et al. Änovel fibronectin binding site required for fibronectin fibrilgrowth during matrix assembly. J Cell Biol 154, 1081-1088 (2001). (Pubitemid 34286186)
32. Smith, M. L. et al. Force-induced unfolding of fibronectin in the extracellularmatrix of living cells. PLoS Biol. 5, e268 (2007).
33. Kubow, K. E. et al. Crosslinking of cell-derived 3D scaffolds up-regulates thestretching and unfolding of new extracellular matrix assembled by reseeded cells.Integr. Biol. 1, 635-648 (2009).
34. Martino, M. M. et al. Controlling integrin specificity and stem cell differentiationin 2D and 3D environments through regulation of fibronectin domain stability.Biomaterials 30, 1089-1097 (2009).
35. Jirouskovä, M., Jaiswal, J. K. & Coller, B. S. Ligand density dramatically affectsintegrin alphäIIb betä3-mediated platelet signaling and spreading. Blood 109,5260-5269 (2007). (Pubitemid 46890546)
36. Maheshwari, G., Brown, G., Lauffenburger, D. A.,Wells, A. & Griffith, L. G. Celladhesion and motility depend on nanoscale RGD clustering. J. Cell Sci.113(Pt 10), 1677-1686 (2000). (Pubitemid 30333117)
37. Martino, M. M. et al. Engineering the growth factor microenvironment withfibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med.3, 100-189 (2011).
38. Yamadä, K. M. & Even-Ram, S. Integrin regulation of growth factor receptors.Nat. Cell Biol. 4, E75-76 (2002). (Pubitemid 34308845)
39. Kuwadä, S. K. & Li, X. Integrin alpha5/beta1 mediates fibronectin-dependentepithelial cell proliferation through epidermal growth factor receptor activation.Mol. Biol. Cell 11, 2485-2496 (2000). (Pubitemid 30489929)
40. Prager-Khoutorsky, M. et al. Fibroblast polarization is ämatrix-rigiditydependentprocess controlled by focal adhesion mechanosensing. Nat. Cell Biol.13, 1-10 (2011).
41. Wood, E. R. et al. Äunique structure for epidermal growth factor receptor boundto GW572016 (Lapatinib): relationships among protein conformation, inhibitoroff-rate, and receptor activity in tumor cells. Cancer Res. 64, 6652-6659 (2004). (Pubitemid 39297926)
42. Ruiz, S. A. & Chen, C. S. Emergence of patterned stem cell differentiation withinmulticellular structures. Stem Cells 26, 2921-2927 (2008).
43. Krammer, A., Craig, D., Thomas, W. E., Schulten, K. & Vogel, V. Ästructuralmodel for force regulated integrin binding to fibronectin's RGD-synergy site.Matrix Biol. 21, 139-147 (2002). (Pubitemid 34145240)
44. Xiä, W., Liu, L.-H., Ho, P. & Spector, N. L. Truncated ErbB2 receptor (p95ErbB2)is regulated by heregulin through heterodimer formation with ErbB3 yet remainssensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016. Oncogene 23,646-653 (2004). (Pubitemid 38241266)
45. Muraoka-Cook, R. S., Feng, S.-M., Strunk, K. E.& Earp, H. S. ErbB4/HER4: role inmammary gland development, differentiation and growth inhibition. J.Mammary Gland Biol. Neoplasiä13, 235-246 (2008).
46. Tamamä, K., Kawasaki, H. &Wells, A. Epidermal growth factor (EGF) treatmenton multipotential stromal cells (MSCs). Possible enhancement of therapeuticpotential of MSC. J. Biomed. Biotechnol. 2010, 795385 (2010).
47. Klapper, L. N. et al. The ErbB-2/HER2 oncoprotein of human carcinomas mayfunction solely as äshared coreceptor for multiple stroma-derived growth factors.Proc. Natl. Acad. Sci. U. S. A. 96, 4995-5000 (1999). (Pubitemid 29214524)
48. Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signalling network. Nat. Rev.Mol. Cell Biol. 2, 127-137 (2001). (Pubitemid 33674041)
49. Platt, M. O., Roman, A. J., Wells, A., Lauffenburger, D. A. & Griffith, L. G.Sustained epidermal growth factor receptor levels and activation by tetheredligand binding enhances osteogenic differentiation of multi-potent marrowstromal cells. J. Cell. Physiol. 221, 306-317 (2009).
50. Martino, M. M. & Hubbell, J. a. The 12th-14th type III repeats of fibronectinfunction as ähighly promiscuous growth factor-binding domain. FASEB J.4711-4721 (2010).
51. Kundu, A. K., Khatiwalä, C. B. & Putnam, A. J. Extracellular matrix remodeling,integrin expression, and downstream signaling pathways influence the osteogenicdifferentiation of mesenchymal stem cells on poly(lactide-co-glycolide)substrates. Tissue Eng. Part Ä15, 273-283 (2009).
52. Baneyx, G., Baugh, L. & Vogel, V. Coexisting conformations of fibronectin in cellculture imaged using fluorescence resonance energy transfer. Proc. Natl. Acad. Sci.U. S. A. 98, 14464-14468 (2001). (Pubitemid 33121414)
53. Engvall, E. & Ruoslahti, E. Binding of soluble form of fibroblast surface protein,fibronectin, to collagen. Int. J. Cancer 20, 1-5 (1977). (Pubitemid 8139735)
54. Mosesson,M.W. & Umfleet, R. A. The cold-insoluble globulin of human plasma.I. Purification, primary characterization, and relationship to fibrinogen and othercold-insoluble fraction components. J. Biol. Chem. 245, 5728-5736 (1970).
55. Mosesson, M. W., Chen, A. B. & Huseby, R. M. The cold-insoluble globulin ofhuman plasma: studies of its essential structural features. Biochim. Biophys. Acta386, 509-524 (1975).
56. Mahaffy, R. E., Shih, C. K., MacKintosh, F. C. & Käs, J. Scanning probe-basedfrequency-dependent microrheology of polymer gels and biological cells. Phys.Rev. Lett. 85, 880-883 (2000).
57. Tse, J. R. & Engler, A. J. Preparation of hydrogel substrates with tunablemechanical properties. Curr. Protoc. Cell. Biol. Chapter 10, Unit 10.16 (2010).